Literature DB >> 28242844

Statistical Methods for Cohort Studies of CKD: Survival Analysis in the Setting of Competing Risks.

Jesse Yenchih Hsu1,2, Jason A Roy3,2, Dawei Xie3,2, Wei Yang3,2, Haochang Shou3,2, Amanda Hyre Anderson3,2, J Richard Landis3,2, Christopher Jepson3,2, Myles Wolf4, Tamara Isakova5,6, Mahboob Rahman7,8,9, Harold I Feldman3,2.   

Abstract

Survival analysis is commonly used to evaluate factors associated with time to an event of interest (e.g., ESRD, cardiovascular disease, and mortality) among CKD populations. Time to the event of interest is typically observed only for some participants. Other participants have their event time censored because of the end of the study, death, withdrawal from the study, or some other competing event. Classic survival analysis methods, such as Cox proportional hazards regression, rely on the assumption that any censoring is independent of the event of interest. However, in most clinical settings, such as in CKD populations, this assumption is unlikely to be true. For example, participants whose follow-up time is censored because of health-related death likely would have had a shorter time to ESRD, had they not died. These types of competing events that cause dependent censoring are referred to as competing risks. Here, we first describe common circumstances in clinical renal research where competing risks operate and then review statistical approaches for dealing with competing risks. We compare two of the most popular analytical methods used in settings of competing risks: cause-specific hazards models and the Fine and Gray approach (subdistribution hazards models). We also discuss practical recommendations for analysis and interpretation of survival data that incorporate competing risks. To demonstrate each of the analytical tools, we use a study of fibroblast growth factor 23 and risks of mortality and ESRD in participants with CKD from the Chronic Renal Insufficiency Cohort Study.
Copyright © 2017 by the American Society of Nephrology.

Entities:  

Keywords:  Cardiovascular Diseases; Cause-specific; Chronic; Cox proportional hazards models; Cumulative incidence function; FGF-23; Fibroblast Growth Factors; Fibroblast growth factor 23; Follow-Up Studies; Kidney Failure; Proportional Hazards Models; Renal Insufficiency; Risk; Survival Analysis

Mesh:

Substances:

Year:  2017        PMID: 28242844      PMCID: PMC5498354          DOI: 10.2215/CJN.10301016

Source DB:  PubMed          Journal:  Clin J Am Soc Nephrol        ISSN: 1555-9041            Impact factor:   10.614


  22 in total

1.  Misspecified regression model for the subdistribution hazard of a competing risk.

Authors:  A Latouche; V Boisson; S Chevret; R Porcher
Journal:  Stat Med       Date:  2007-02-28       Impact factor: 2.373

2.  A competing risks analysis of bloodstream infection after stem-cell transplantation using subdistribution hazards and cause-specific hazards.

Authors:  Jan Beyersmann; Markus Dettenkofer; Hartmut Bertz; Martin Schumacher
Journal:  Stat Med       Date:  2007-12-30       Impact factor: 2.373

3.  Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease.

Authors:  Tamara Isakova; Huiliang Xie; Wei Yang; Dawei Xie; Amanda Hyre Anderson; Julia Scialla; Patricia Wahl; Orlando M Gutiérrez; Susan Steigerwalt; Jiang He; Stanley Schwartz; Joan Lo; Akinlolu Ojo; James Sondheimer; Chi-yuan Hsu; James Lash; Mary Leonard; John W Kusek; Harold I Feldman; Myles Wolf
Journal:  JAMA       Date:  2011-06-15       Impact factor: 56.272

4.  The analysis of failure times in the presence of competing risks.

Authors:  R L Prentice; J D Kalbfleisch; A V Peterson; N Flournoy; V T Farewell; N E Breslow
Journal:  Biometrics       Date:  1978-12       Impact factor: 2.571

5.  Applying Cox regression to competing risks.

Authors:  M Lunn; D McNeil
Journal:  Biometrics       Date:  1995-06       Impact factor: 2.571

6.  Competing risk regression models for epidemiologic data.

Authors:  Bryan Lau; Stephen R Cole; Stephen J Gange
Journal:  Am J Epidemiol       Date:  2009-06-03       Impact factor: 4.897

7.  The Chronic Renal Insufficiency Cohort (CRIC) Study: Design and Methods.

Authors:  Harold I Feldman; Lawrence J Appel; Glenn M Chertow; Denise Cifelli; Borut Cizman; John Daugirdas; Jeffrey C Fink; Eunice D Franklin-Becker; Alan S Go; L Lee Hamm; Jiang He; Tom Hostetter; Chi-Yuan Hsu; Kenneth Jamerson; Marshall Joffe; John W Kusek; J Richard Landis; James P Lash; Edgar R Miller; Emile R Mohler; Paul Muntner; Akinlolu O Ojo; Mahboob Rahman; Raymond R Townsend; Jackson T Wright
Journal:  J Am Soc Nephrol       Date:  2003-07       Impact factor: 10.121

8.  Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function.

Authors:  James P Lash; Alan S Go; Lawrence J Appel; Jiang He; Akinlolu Ojo; Mahboob Rahman; Raymond R Townsend; Dawei Xie; Denise Cifelli; Janet Cohan; Jeffrey C Fink; Michael J Fischer; Crystal Gadegbeku; L Lee Hamm; John W Kusek; J Richard Landis; Andrew Narva; Nancy Robinson; Valerie Teal; Harold I Feldman
Journal:  Clin J Am Soc Nephrol       Date:  2009-06-18       Impact factor: 8.237

9.  Methods of competing risks analysis of end-stage renal disease and mortality among people with diabetes.

Authors:  Hyun J Lim; Xu Zhang; Roland Dyck; Nathaniel Osgood
Journal:  BMC Med Res Methodol       Date:  2010-10-21       Impact factor: 4.615

10.  Flexible parametric modelling of cause-specific hazards to estimate cumulative incidence functions.

Authors:  Sally R Hinchliffe; Paul C Lambert
Journal:  BMC Med Res Methodol       Date:  2013-02-06       Impact factor: 4.615

View more
  21 in total

1.  Nonparametric Assessment of Differences Between Competing Risk Hazard Ratios: Application to Racial Differences in Pediatric Chronic Kidney Disease Progression.

Authors:  Derek K Ng; Daniel A Antiporta; Matthew B Matheson; Alvaro Muñoz
Journal:  Clin Epidemiol       Date:  2020-01-20       Impact factor: 4.790

2.  Coffee Consumption and Incident Kidney Disease: Results From the Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  Emily A Hu; Elizabeth Selvin; Morgan E Grams; Lyn M Steffen; Josef Coresh; Casey M Rebholz
Journal:  Am J Kidney Dis       Date:  2018-03-20       Impact factor: 8.860

3.  Vitamin K status, all-cause mortality, and cardiovascular disease in adults with chronic kidney disease: the Chronic Renal Insufficiency Cohort.

Authors:  M Kyla Shea; Kathryn Barger; Sarah L Booth; Jifan Wang; Harold I Feldman; Raymond R Townsend; Jing Chen; John Flack; Jiang He; Bernard G Jaar; Mayank Kansal; Sylvia E Rosas; Daniel E Weiner
Journal:  Am J Clin Nutr       Date:  2022-03-04       Impact factor: 8.472

4.  Serum Calcification Propensity and Clinical Events in CKD.

Authors:  Joshua D Bundy; Xuan Cai; Rupal C Mehta; Julia J Scialla; Ian H de Boer; Chi-Yuan Hsu; Alan S Go; Mirela A Dobre; Jing Chen; Panduranga S Rao; Mary B Leonard; James P Lash; Geoffrey A Block; Raymond R Townsend; Harold I Feldman; Edward R Smith; Andreas Pasch; Tamara Isakova
Journal:  Clin J Am Soc Nephrol       Date:  2019-10-28       Impact factor: 8.237

5.  Sex Differences in Cardiovascular Outcomes in CKD: Findings From the CRIC Study.

Authors:  Stephanie M Toth-Manikowski; Wei Yang; Lawrence Appel; Jing Chen; Rajat Deo; Anne Frydrych; Marie Krousel-Wood; Mahboob Rahman; Sylvia E Rosas; Daohang Sha; Jackson Wright; Martha L Daviglus; Alan S Go; James P Lash; Ana C Ricardo
Journal:  Am J Kidney Dis       Date:  2021-04-20       Impact factor: 11.072

6.  Age Modifies the Association of Dietary Protein Intake with All-Cause Mortality in Patients with Chronic Kidney Disease.

Authors:  Daiki Watanabe; Shinji Machida; Naoki Matsumoto; Yugo Shibagaki; Tsutomu Sakurada
Journal:  Nutrients       Date:  2018-11-13       Impact factor: 5.717

Review 7.  Risk Factors for CKD Progression: Overview of Findings from the CRIC Study.

Authors:  Mary Hannan; Sajid Ansari; Natalie Meza; Amanda H Anderson; Anand Srivastava; Sushrut Waikar; Jeanne Charleston; Matthew R Weir; Jonathan Taliercio; Edward Horwitz; Milda R Saunders; Katherine Wolfrum; Harold I Feldman; James P Lash; Ana C Ricardo
Journal:  Clin J Am Soc Nephrol       Date:  2020-11-11       Impact factor: 8.237

8.  Predicting mortality in hemodialysis patients using machine learning analysis.

Authors:  Victoria Garcia-Montemayor; Alejandro Martin-Malo; Carlo Barbieri; Francesco Bellocchio; Sagrario Soriano; Victoria Pendon-Ruiz de Mier; Ignacio R Molina; Pedro Aljama; Mariano Rodriguez
Journal:  Clin Kidney J       Date:  2020-08-11

9.  Association of Kidney Disease Quality of Life (KDQOL-36) with mortality and hospitalization in older adults receiving hemodialysis.

Authors:  Rasheeda K Hall; Alison Luciano; Carl Pieper; Cathleen S Colón-Emeric
Journal:  BMC Nephrol       Date:  2018-01-15       Impact factor: 2.388

10.  Kidney Clearance of Secretory Solutes Is Associated with Progression of CKD: The CRIC Study.

Authors:  Yan Chen; Leila R Zelnick; Ke Wang; Andrew N Hoofnagle; Jessica O Becker; Chi-Yuan Hsu; Harold I Feldman; Rupal C Mehta; James P Lash; Sushrut S Waikar; Tariq Shafi; Stephen L Seliger; Michael G Shlipak; Mahboob Rahman; Bryan R Kestenbaum
Journal:  J Am Soc Nephrol       Date:  2020-03-23       Impact factor: 10.121

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.